{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/fda/warning-letters/check?name=Integrity%20Partners%20Group","name":"Integrity Partners Group","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-07-30T04:49:53.976Z"},"count":1,"matches":[{"id":"9fc6e78f146f9201","posted_date":"2026-01-20","letter_issue_date":"2025-12-15","company_name":"Integrity Partners Group","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.ai-analytics.org/fda-warning/9fc6e78f146f9201"}]}